This live document captures the Network’s growing impact—highlighting the milestones achieved, the lessons learned and the foundation we’ve built for the next phase of our journey!
When autocomplete results are available use up and down arrows to review and enter to select.
In a new study published in Nature Medicine, a team of Network researchers uncovered how tumours develop resistance to a specific type of immunotherapy targeted to a molecule called GPRC5D.
The overall vision of the PR2C is to create a collaborative, inclusive, equitable, and sustainable multiprovincial initiative that works towards developing new treatment strategies for patients facing...